Heme oxygenase 1 (HO‐1) regulates osteoclastogenesis and bone resorption
@article{Zwerina2005HemeO1,
title={Heme oxygenase 1 (HO‐1) regulates osteoclastogenesis and bone resorption},
author={Jochen Zwerina and Sotiria Tzima and Silvia Hayer and Kurt Redlich and Oskar Hoffmann and Beatrice Hanslik-Schnabel and Josef S. Smolen and George Kollias and Georg Schett},
journal={The FASEB Journal},
year={2005},
volume={19}
}Heme oxygenase 1 (HO‐1) plays an important role in vascular disease, transplantation, and inflammation. In animal models of acute and chronic inflammation, induction of HO‐1 has anti‐inflammatory and cytoprotective properties. Since inflammation is an important trigger of osteoclastogenesis, we hypothesized that HO‐1 might influence osteoclastogenesis. We investigated the effects of induction of HO‐1 on osteoclast formation in vitro and in vivo. Furthermore, we addressed the role of HO‐1 in…
Topics from this paper
116 Citations
Upregulation of heme oxygenase‐1 inhibits the maturation and mineralization of osteoblasts
- BiologyJournal of cellular physiology
- 2010
The results showed that induction of HO‐1 inhibited the maturation of osteoblasts including mineralized bone nodule formation, alkaline phosphatase activity and decreased mRNA expression of several differentiation markers such as alkaline phosphate, osteocalcin, and RUNX2.
Bach1 regulates osteoclastogenesis in a mouse model via both heme oxygenase 1-dependent and heme oxygenase 1-independent pathways.
- Biology, MedicineArthritis and rheumatism
- 2012
The present findings demonstrate that Bach1 regulates osteoclastogenesis under inflammatory conditions, via both HO-1-dependent and HO- 1-independent mechanisms.
Hemeoxygenase-1 maintains bone mass via attenuating a redox imbalance in osteoclast
- Biology, MedicineMolecular and Cellular Endocrinology
- 2015
Suppression of RANKL‐dependent heme oxygenase‐1 is required for high mobility group box 1 release and osteoclastogenesis
- BiologyJournal of cellular biochemistry
- 2012
It is reported that RANKL‐induced suppression of heme oxygenase‐1 (HO‐1), a heme‐degrading enzyme, promotes HMGB1 release during osteoclastogenesis and suggests that RankL‐dependent HO‐1 suppression leads to caspase‐3 activation and HMGB 1 release during bone marrow‐derived macrophages and RAW‐D precursor cells.
Heme oxygenase-1 mediates protective effects on inflammatory, catabolic and senescence responses induced by interleukin-1β in osteoarthritic osteoblasts.
- Biology, MedicineBiochemical pharmacology
- 2012
Heme oxygenase-1 mediates protective effects on inflammatory , catabolic and senescence responses induced by interleukin-1 b in osteoarthritic osteoblasts
- Biology, Medicine
- 2011
The results have shown that HO-1 decreases the production of relevant inflammatory and catabolic mediators that participate in OA pathophysiology thus eliciting protective effects in O a osteoblasts.
Various roles of heme oxygenase-1 in response of bone marrow macrophages to RANKL and in the early stage of osteoclastogenesis
- BiologyScientific Reports
- 2018
The data indicate that HO-1 is involved in the response of bone marrow macrophages to RANKL and the induction of OCLs markers, but it is dispensable in early-stage O CLs.
Heme Oxygenase-1 (HO-1) Expression in Prostate Cancer Cells Modulates the Oxidative Response in Bone Cells
- BiologyPloS one
- 2013
It is demonstrated that HO-1 pharmacological induction (hemin treatment) abrogated the diminution of PMOs proliferation induced by PCa cells and decreased the expression of osteoclast-modulating factors in osteoblasts.
Trolox Prevents Osteoclastogenesis by Suppressing RANKL Expression and Signaling*
- Biology, MedicineJournal of Biological Chemistry
- 2009
The findings indicate that Trolox prevents osteoclast formation and bone loss by inhibiting both RANKL induction in osteoblasts and c-Fos expression in osteOClast precursors.
Dual role of VEGF-induced heme-oxygenase-1 in angiogenesis.
- BiologyAntioxidants & redox signaling
- 2006
It is proposed that during chronic inflammation, HO-1 has two roles, first an antiinflammatory action inhibiting leukocyte infiltration, and second, promotion of VEGF-driven noninflammatory angiogenesis, which facilitates tissue repair.
References
SHOWING 1-10 OF 51 REFERENCES
Heme oxygenase‐1 protects against apoptosis induced by tumor necrosis factor‐α and cycloheximide in papillary thyroid carcinoma cells
- Biology
- 2004
It is revealed that an increase in the level of HO‐1 markedly reduces the sensitivity of papillary thyroid carcinoma cells to apoptotic stimuli and can be suppressed by inhibiting NF‐kappaB.
Potential role of heme oxygenase-1 in the progression of rat adjuvant arthritis
- Biology, MedicineLaboratory Investigation
- 2005
Rat adjuvant arthritis is an experimental model widely used to evaluate etiopathogenetic mechanisms in chronic inflammation and results support a role for heme oxygenase-1 in mediating the progression of the disease in this model of chronic arthritis.
Beneficial Effects of Heme Oxygenase-1 Up-Regulation in the Development of Experimental Inflammation Induced by Zymosan
- BiologyJournal of Pharmacology and Experimental Therapeutics
- 2003
The results indicate that HO-1 exerts anti-inflammatory effects on the response to zymosan in the mouse air pouch and support a role for this enzyme in the modulation of inflammatory processes.
Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice
- Biology, ChemistryNature Medicine
- 2002
In murine macrophages, IL-10 induces expression of heme oxygenase-1 (HO-1), a stress-inducible protein with potential anti-inflammatory effect, via a p38 mitogen-activated protein kinase-dependent pathway, which provides new possibilities for improved therapeutic approaches for treating inflammatory diseases.
Osteoclasts are essential for TNF-alpha-mediated joint destruction.
- Biology, MedicineThe Journal of clinical investigation
- 2002
Osteoclast inhibition could be beneficial for the treatment of rheumatoid arthritis because it reveals that TNF-dependent bone erosion is mediated by osteoclast and that the absence of osteoclasts alters T NF-mediated arthritis from a destructive to a nondestructive arthritis.
TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.
- BiologyThe Journal of clinical investigation
- 2000
While TNF-alpha alone does not induce osteoclastogenesis, it does so both in vitro and in vivo by directly targeting macrophages within a stromal environment that expresses permissive levels of RANKL, indicating a more convenient target in arresting inflammatory osteolysis.
Heme Oxygenase-1 Modulates the Expression of Adhesion Molecules Associated with Endothelial Cell Activation1
- BiologyThe Journal of Immunology
- 2004
Heme oxygenase-1 inhibits the expression of proinflammatory genes associated with EC activation via a mechanism that is associated with the inhibition of NF-κB activation.
Induction of heme oxygenase-1 gene expression by lipopolysaccharide is mediated by AP-1 activation.
- BiologyAmerican journal of respiratory cell and molecular biology
- 1995
It is demonstrated that LPS induces high mRNA levels of the stress-inducible gene heme oxygenase-1 (HO-1) in the rat lung and the molecular regulation of HO-1 gene expression after exposure of RAW 264.7 macrophage cells to LPS is examined.
Heme oxygenase-1 protects against apoptosis induced by tumor necrosis factor-alpha and cycloheximide in papillary thyroid carcinoma cells.
- BiologyJournal of cellular biochemistry
- 2004
It is revealed that an increase in the level of HO-1 markedly reduces the sensitivity of papillary thyroid carcinoma cells to apoptotic stimuli and can be suppressed by inhibiting NF-kappaB.
Chemical induction of HO‐1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti‐dsDNA antibody
- Medicine, BiologyClinical and experimental immunology
- 2004
The results suggest that HO‐1 induction therapy ameliorates lupus nephritis by suppressing nitric oxide (NO) dependent inflammatory responses and attenuating production of pathogenic autoantibodies.